ERCC6L and pheochromocytoma-paraganglioma: However, the ERCC6L expression level was not correlated with the overall survival (OS) of patients with BLCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, LAML, OV, Pheochromocytoma/paraganglioma (PCPG), PRAD, TGCT, THCA, or UCS (Figs. S5A–O).